AZCERT Announces Open Access to Medsafety Scan® for Safe Prescribing During COVID-19 Pandemic

The decision support system is available free to medical professionals around the world.

(INFORMATION EMBARGOED UNTIL 10 A.M. EASTERN 4/20/2020) 

 

 

Newswise — TUCSON, Ariz., April 20, 2020 — The Arizona Center for Education and Research on Therapeutics (AZCERT), a nonprofit dedicated to the safe use of medicines, is making MedSafety Scan®, a web-based decision support system, available free to medical professionals around the world, especially those treating high risk COVID-19 patients. MedSafety Scan® can warn healthcare providers when their patients are prescribed drugs that place them at high risk of developing a potentially lethal cardiac arrhythmia known as torsades de pointes (TdP). MedSafety Scan® also checks for potentially dangerous drug-interactions and suggests options for how to monitor the patient and reduce their risk of harm.

Several of the medications now being tested or prescribed for COVID-19 (e.g. chloroquine, hydroxychloroquine, azithromycin) can cause TdP which, although rare, occurs more often in patients with medical conditions that are commonly found in very ill COVID-19 patients. 

“Our goal is to equip healthcare providers with this important prescribing tool as they face this global crisis,” said AZCERT founder and President Ray Woosley, MD, PhD. For nearly 20 years, AZCERT has been providing the public and healthcare professionals information on drug safety through its website crediblemeds.org. It is internationally recognized as the single source for a database known as QTdrugs. AZCERT’s new program, MedSafety Scan®, utilizes QTdrugs and patient data to make recommendations that are immediately relevant to each patient.

Even though many hospitals and healthcare systems, including Banner Health, Mayo Clinic, Indiana University, Honor Health and hospital systems in Belgium and the Netherlands, use AZCERT’s QTdrugs database to detect patients at risk of TdP, many healthcare professionals lack such support. With the launch of medsafetyscan.org, anyone can now gain free access to the QTdrugs database and the decision support they need for optimal decision-making when prescribing for patients with COVID-19.

Healthcare professionals can register at medsafetyscan.org to create a free account that allows them to enter de-identified basic medical information about each of their patients. MedSafety Scan® calculates a TdP risk score and, when elevated, will inform the clinician of the magnitude of TdP risk (Very High, High or Moderate) and provide suggestions to manage that risk. The suggestions may include changing to an alternate drug with less arrhythmia risk or to monitor the patient’s electrocardiogram or electrolytes. 

AZCERT’s MedSafety Scan® is made available as a point of care resource for healthcare professionals during this COVID-19 healthcare crisis. 

About AZCERT

AZCERT (Arizona CERT) was founded in 1999 as one of 14 university-based, federally funded Centers for Education and Research on Therapeutics (CERTs), with a mission to foster the safe use of medicines. In 2012, AZCERT became an independent nonprofit organization incorporated in Arizona. AZCERT's website was renamed CredibleMeds® in 2014 to better reflect its scope and global recognition as a trusted resource on the safe use of medications for healthcare providers, research scientists and the public. AZCERT maintains CredibleMeds' databases and its many resources and is best known for the QTdrugs lists of drugs that have a risk of QT prolongation and cardiac arrhythmias. For more information, visit crediblemeds.org.

 




Filters close

Showing results

110 of 2454
Released: 3-Jul-2020 10:25 AM EDT
Lack of lockdown increased COVID-19 deaths in Sweden
University of Virginia Health System

Sweden’s controversial decision not to lock down during COVID-19 produced more deaths and greater healthcare demand than seen in countries with earlier, more stringent interventions, a new analysis finds.

Released: 2-Jul-2020 3:10 PM EDT
Researchers outline adapted health communications principles for the COVID-19 pandemic
CUNY Graduate School of Public Health and Health Policy

The COVID-19 pandemic has introduced unique challenges for public health practitioners and health communicators that warrant an expansion of existing health communication principles to take into consideration.

Released: 2-Jul-2020 1:40 PM EDT
Collectivism drives efforts to reduce the spread of COVID-19
University of Kent

Research from the University of Kent has found that people who adopt a collectivist mindset are more likely to comply with social distancing and hygiene practices to help reduce the spread of COVID-19.

Released: 2-Jul-2020 12:30 PM EDT
Tiny mineral particles are better vehicles for promising gene therapy
University of Wisconsin-Madison

University of Wisconsin–Madison researchers have developed a safer and more efficient way to deliver a promising new method for treating cancer and liver disorders and for vaccination — including a COVID-19 vaccine from Moderna Therapeutics that has advanced to clinical trials with humans.

Newswise: Newer variant of COVID-19–causing virus dominates global infections
Released: 2-Jul-2020 12:10 PM EDT
Newer variant of COVID-19–causing virus dominates global infections
Los Alamos National Laboratory

Research out today in the journal Cell shows that a specific change in the SARS-CoV-2 coronavirus virus genome, previously associated with increased viral transmission and the spread of COVID-19, is more infectious in cell culture.

Newswise: From Wuhan to San Diego—How a mutation on the novel coronavirus has come to dominate the globe
Released: 2-Jul-2020 12:05 PM EDT
From Wuhan to San Diego—How a mutation on the novel coronavirus has come to dominate the globe
La Jolla Institute for Immunology

Two variants of the novel coronavirus (SARS-CoV-2), called G614 and D614, were circulating in mid-March. A new study shows that the G version of the virus has come to dominate cases around the world. They report that this mutation does not make the virus more deadly, but it does help the virus copy itself, resulting in a higher viral load, or "titer," in patients.

Released: 2-Jul-2020 11:50 AM EDT
New Study Explains Potential Causes for “Happy Hypoxia” Condition in COVID-19 Patients
Loyola Medicine

A new research study provides possible explanations for COVID-19 patients who present with extremely low, otherwise life-threatening levels of oxygen, but no signs of dyspnea (difficulty breathing). This new understanding of the condition, known as silent hypoxemia or “happy hypoxia,” could prevent unnecessary intubation and ventilation in patients during the current and expected second wave of coronavirus.

Released: 2-Jul-2020 10:15 AM EDT
Stemming the Spread of Misinformation on Social Media
Association for Psychological Science

New research reported in the journal Psychological Science finds that priming people to think about accuracy could make them more discerning in what they subsequently share on social media.

29-Jun-2020 9:00 AM EDT
Coronavirus damages the endocrine system
Endocrine Society

People with endocrine disorders may see their condition worsen as a result of COVID-19, according to a new review published in the Journal of the Endocrine Society.


Showing results

110 of 2454

close
1.19246